Ophthalmic Moxifloxacin


edge pharma testing4


Edge Pharma offers moxifloxacin ophthalmic antimicrobial injection for use by hospitals and surgery centers. It is offered in unit dose syringes.


Moxifloxacin Ophthalmic Injection

  • Balanced Salt Solution
  • Concentration = 1.0 mg/mL
  • Syringe Volume = 0.8 mL
  • Note: Formulation does not contain Xanthan Gum.



1) Haripriya, Aravind, et al. "Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital." Ophthalmology 123.2 (2016): 302-308.

"Routine IC moxifloxacin prophylaxis achieved a highly significant, 4-fold reduction in postoperative endophthalmitis in patients undergoing M-SICS. Compared with previous studies, having such a high volume of patients undergoing surgery during a relatively short 14-month time period strengthens the conclusion. This study provides further evidence that moxifloxacin is an effective IC prophylactic antibiotic and suggests that IC antibiotics should be considered for M-SICS and phacoemulsification."

2) Haripriya, Aravind, David F. Chang, and Ravilla D. Ravindran. "Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries." Ophthalmology (2017).

"Overall, 302 815 eyes did not receive IC moxifloxacin and 314 638 eyes did, and there was a significant decline in the endophthalmitis rate, from 0.07% (214/302 815) to 0.02% (64/314 638) (P < 0.001), with moxifloxacin."

"There was also a statistical benefit for eyes complicated by PCR, and IC antibiotic prophylaxis should be strongly considered for this high-risk population."


Register To Order Online 

We are currently licensed to sell to all US states except Alabama and Virginia. Please fill the Form below to create an account. Medical, DEA, or hospital pharmacy licenses will be required to order ophthalmic moxifloxacin syringes.

Create an account to order

Log-In if you have an account